MarketCapTrends
PBYI

Puma Biotechnology Inc. (PBYI)

NASDAQ · Healthcare

Puma Biotechnology Inc. annual/quarterly total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Puma Biotechnology Inc. total liabilities for the quarter ending December 31, 2025 were 86.0M, a 29.08% decrease year-over-year.
  • Puma Biotechnology Inc. total liabilities for 2025 were 86.0M, a 29.08% decrease from 2024.
  • Puma Biotechnology Inc. total liabilities for 2024 were 121.2M, a 31.55% decrease from 2023.
  • Puma Biotechnology Inc. total liabilities for 2023 were 177.1M, a 11.66% decrease from 2022.
  • Puma Biotechnology Inc. total liabilities for 2022 were 200.5M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Puma Biotechnology Inc. Annual Total Liabilities (Millions of US $)
2025$86
2024$121
2023$177
2022$200
2021$229
2020$250
2019$217
2018$225
2017$112
Puma Biotechnology Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$86
2024-12-31$121
2023-12-31$177
2022-12-31$200
2021-12-31$229
2020-12-31$250
2019-12-31$217
2018-12-31$225
2017-12-31$112

Puma Biotechnology Inc. Total Liabilities — FAQ

Puma Biotechnology Inc. (PBYI) total liabilities over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see PBYI's total liabilities history?

The chart and table above show Puma Biotechnology Inc.'s total liabilities by year and by quarter, including the growth rate.